Throughout the last three months, 16 analysts have evaluated Ecolab ECL, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 7 | 7 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 1 | 2 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 5 | 0 | 0 |
3M Ago | 1 | 3 | 2 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $250.38, a high estimate of $270.00, and a low estimate of $225.00. Observing a 5.0% increase, the current average has risen from the previous average price target of $238.46.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into how financial experts perceive Ecolab. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
Joshua Spector | UBS | Raises | Buy | $270.00 | $269.00 |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | - |
Patrick Cunningham | Citigroup | Raises | Neutral | $257.00 | $256.00 |
Ashish Sabadra | RBC Capital | Raises | Outperform | $260.00 | $238.00 |
John McNulty | BMO Capital | Raises | Market Perform | $234.00 | $227.00 |
Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $225.00 | $220.00 |
Shlomo Rosenbaum | Stifel | Raises | Hold | $233.00 | $225.00 |
Andrew Wittmann | Baird | Raises | Neutral | $243.00 | $232.00 |
John Roberts | Mizuho | Raises | Buy | $260.00 | $216.00 |
Patrick Cunningham | Citigroup | Raises | Neutral | $256.00 | $237.00 |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $238.00 | - |
Pavel Molchanov | Raymond James | Raises | Outperform | $250.00 | $230.00 |
Charles Neivert | Piper Sandler | Announces | Overweight | $260.00 | - |
Vincent Andrews | Morgan Stanley | Raises | Equal-Weight | $240.00 | $230.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ecolab. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Ecolab's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Ecolab analyst ratings.
All You Need to Know About Ecolab
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
Unraveling the Financial Story of Ecolab
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Over the 3 months period, Ecolab showcased positive performance, achieving a revenue growth rate of 5.05% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Ecolab's net margin is impressive, surpassing industry averages. With a net margin of 10.98%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ecolab's ROE stands out, surpassing industry averages. With an impressive ROE of 5.07%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Ecolab's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.91%, the company showcases efficient use of assets and strong financial health.
Debt Management: Ecolab's debt-to-equity ratio stands notably higher than the industry average, reaching 0.99. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Understanding the Relevance of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.